The Recombinant Proteins Market is expected to grow from USD 1.0 billion in 2020 to USD 1.7 billion by 2026 at a CAGR of 9.8% from 2020 to 2026.
Recombinant proteins are the new combination of genes which can be used in the formation of DNA. Recombinant DNA technology assists in the production of wild type and modified human, mammalian proteins in mass quantities. The proteins are made from cloned DNA sequences which usually encode an enzyme or protein with the known function. They are made through genetic engineering, which is also known as gene splicing or recombinant DNA technology. The recombinants can be gain by putting human, animal, or plant genes into the genetic material of mammalian, bacteria, or yeast cells. Government initiate for the prevention of bacterial diseases and increasing elderly diseases population and this resultant in a rise in infected disease prevalence, the requirement for affordable treatment options and digitalization of healthcare systems are factors which will accelerate the global recombinant protein market during the forecast period. Recombinant protein is technologically advance and is designed specifically to enhance health outcomes at any point. Additionally, in the real world, practical applications of these technologies can enhance the individual’s health and boost better outcomes of the population as a whole. The technological advancement in population health expands beyond big data applications for quality assessment and benchmarking capabilities. Also, technology allows the rapid aggregation of individual patient’s data to identify key patterns in large populations. Advancement in technology which supports recombinant protein such as to maintain patient dashboard, remote patient monitoring clinical grade, data aggregation, automated care management outreach, telemedicine, clinical intelligence/analytics, patient engagement, risk stratification. Thus, the effect of this factor on the recombinant protein market is projected to increase soon with constantly evolving technologies. On the other hand, dearth of data management expertise and skilled analysts, hesitancy to move from conventional systems and safety concerns pertaining to patient information are few of the major constraints on recombinant protein market growth.
Furthermore, the Asia Pacific region is anticipated to provide potential growth opportunities to market players in the coming years, owing to the diversified healthcare markets in this region, the rising incidence of infectious and chronic disorders, and increasing R&D initiatives to develop innovative proteomic and genomic techniques. In addition, the growth of the aging population, rising income levels, developments in healthcare infrastructure, rising healthcare expenditure, and the low-cost manufacturing benefit provided by emerging APAC countries are likely to prompt market players to invest in the region. Regulatory policies in Asia are also more flexible and business-friendly, which caters to attract the attention of large corporations already facing growing competition in mature markets.
The global Recombinant Proteins Market is segregated on the basis of Type of Product as Antibodies, Hormones, Growth Factors, Cytokines and Others. Based on Application the global Recombinant Proteins Market is segmented in Therapeutic Use, Research Application and Biotechnology Industry. Based on End User the global Recombinant Proteins Market is segmented in Biotechnology Companies, Research Institutes and Others.
The global Recombinant Proteins Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Recombinant Proteins Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Analysis
Thermo Fisher Scientific, Inc., Miltenyi Biotech, Sino Biological Inc., Merck KGaA, Abcam plc and others are among the major players in the global Recombinant Proteins Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Recombinant Proteins Market has been segmented as below:
Recombinant Proteins Market, By Type of Product
Recombinant Proteins Market, By Application
Recombinant Proteins Market, By End User
Recombinant Proteins Market, By Region
Recombinant Proteins Market, By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Recombinant Proteins Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Recombinant Proteins Market share. Major industry players with significant revenue share include Thermo Fisher Scientific, Inc., Miltenyi Biotech, Sino Biological Inc., Merck KGaA, Abcam plc and others.
Why to Buy this Report:
Target Audience:
Free and Paid Customization based on the requirement
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Recombinant Proteins Market, By Type of Product
5.1. Key Points
5.2. Antibodies
5.3. Hormones
5.4. Growth Factors
5.5. Cytokines
5.6. Others
6. Recombinant Proteins Market, By Application
6.1. Key Points
6.2. Therapeutic Use
6.3. Research Application
6.4. Biotechnology Industry
7. Recombinant Proteins Market, By End User
7.1. Key Points
7.2. Biotechnology Companies
7.3. Research Institutes
7.4. Others
8. Competitive Landscape
8.1. Introduction
8.2. Start-up companies- Recombinant Proteins Market
8.3. Recent Developments
8.3.1. Mergers & Acquisitions
8.3.2. New Product Developments
8.3.3. Portfolio/Production Capacity Expansions
8.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5. Others
9. Company Profile
9.1. Thermo Fisher Scientific, Inc.
9.2. Miltenyi Biotech
9.3. Sino Biological Inc.
9.4. Merck KGaA
9.5. Abcam plc
9.6. Biolegend
9.7. Bio-Rad Laboratories, Inc.
9.8. GenScript Biotech Corporation
9.9. Enzo Life Sciences, Inc.
9.10. BPS Bioscience, Inc.
9.11. PeproTech, Inc.
9.12. Proteintech Group, Inc.
9.13. Abnova Corporation
9.14. R&D Systems
9.15. STEMCELL Technologies Inc
9.16. RayBiotech Inc
9.17. CellGenix GmbH
9.18. ACROBiosystems
9.19. ProSpec-TechnoGene Ltd.
9.20. Neuromics
9.21. RICHCORE LIFESCIENCES PVT LTD
9.22. Icosagen AS
9.23. ProteoGenix
9.24. United States Biological
Recombinant Proteins Market, By Type of Product
Recombinant Proteins Market, By Application
Recombinant Proteins Market, By End User
Recombinant Proteins Market, By Company